Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections.
Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections. J Control Release. 2013 Aug 28; 170(1):64-73.
View in:
PubMed
subject areas
Animals
Animals
Anti-Bacterial Agents
Anti-Bacterial Agents
Arthroplasty, Replacement
Arthroplasty, Replacement
Bacterial Infections
Bacterial Infections
Drug Delivery Systems
Drug Delivery Systems
Female
Female
Fusidic Acid
Fusidic Acid
Lactic Acid
Lactic Acid
Methicillin-Resistant Staphylococcus aureus
Methicillin-Resistant Staphylococcus aureus
Microbial Sensitivity Tests
Microbial Sensitivity Tests
Nanofibers
Nanofibers
Polyglycolic Acid
Polyglycolic Acid
Prostheses and Implants
Prostheses and Implants
Prosthesis-Related Infections
Prosthesis-Related Infections
Rats
Rats
Rats, Sprague-Dawley
Rats, Sprague-Dawley
Rifampin
Rifampin
Staphylococcus epidermidis
Staphylococcus epidermidis